Menu Search
Equities

GE Healthcare Technologies Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
L0T:BRN

GE Healthcare Technologies Inc

Actions
  • Price (--)--
  • Today's Change--
  • Shares traded--
  • 1 Year change--
  • Beta--
--
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

GE HealthCare Technologies Inc. is a healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first artificial intelligence (AI)-enabled solutions, services and data analytics. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.

  • Revenue in USD (TTM)20.63bn
  • Net income in USD2.09bn
  • Incorporated2022
  • Employees54.00k
  • Location
    GE Healthcare Technologies Inc500 West Monroe StreetCHICAGO 60661United StatesUSA
  • Phone+1 (203) 360-4369
  • Fax+1 (302) 655-5049
  • Websitehttps://www.gehealthcare.com
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		GEHC:NSQ since
announced		Transaction
value
Intelerad Medical Systems IncAnnounced20 Nov 202520 Nov 2025Announced11.53%2.30bn
Icometrix NVAnnounced10 Sep 202510 Sep 2025Announced2.46%--
Data delayed at least 15 minutes, as of Feb 06 2026 21:00 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.